Literature DB >> 8550866

The subgingival microflora and gingival crevicular fluid cytokines in refractory periodontitis.

H J Lee1, I K Kang, C P Chung, S M Choi.   

Abstract

Refractory periodontitis manifests as a rapid, unrelenting, progressive loss of attachment despite the type and frequency of therapy. This study examined possible relationships between cytokine levels in gingival crevicular fluid (GCF), occurrence of specific periodontopathic microflora, and disease activity in patients with refractory periodontitis. Refractory periodontitis patients (7 male and 3 female) were selected on the basis of history and longitudinal clinical observations. In each patient, 2 teeth with pocket depths greater than 6 mm were selected and individual acrylic stents were fabricated with reference grooves for each site. The sites were examined at both baseline and 3 months later. The pattern and amount of alveolar bone resorption were assayed by quantitative digital subtraction radiography. Pocket depth and attachment loss were measured with a Florida Probe. The gingival index was measured at 4 sites around each sample tooth. Sites were divided into active sites (> or = 2.1 mm loss of attachment in 3 months) or inactive sites (< or = 2.0 mm loss of attachment in 3 months). The distribution and prevalence of the predominant microflora in active and inactive sites were compared using anaerobic culture and indirect immunofluorescence. Interleukin-1 beta, 2, 4, 6 and tumor necrosis factor-alpha (TNF-alpha) levels in gingival crevicular fluid (GCF) were quantified by ELISA. Prevotella intermedia and Eikenella corrodens significantly decreased in inactive sites but remained the same in active sites after 3 months. The active sites revealed significantly higher GCF levels of IL-2 and IL-6 than inactive sites at both baseline and at 3 months. IL-1 beta was also significantly greater in active sites than in inactive sites at 3 months. Alveolar bone loss in active sites correlated with increased GCF levels of IL-1 beta and IL-2. These results suggest that GCF levels of IL-1 beta, IL-2 and IL-6 and P. intermedia and E. corrodens in subgingival plaque may serve as possible indicators of disease activity in refractory periodontitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8550866     DOI: 10.1111/j.1600-051x.1995.tb01788.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  31 in total

1.  Correlations between pentraxin 3 or cytokine levels in gingival crevicular fluid and clinical parameters of chronic periodontitis.

Authors:  Yuzo Fujita; Hiroshi Ito; Satoshi Sekino; Yukihiro Numabe
Journal:  Odontology       Date:  2011-09-20       Impact factor: 2.634

2.  Connective tissue graft plus resin-modified glass ionomer restoration for the treatment of gingival recession associated with non-carious cervical lesions: microbiological and immunological results.

Authors:  Mauro Pedrine Santamaria; Marcio Zaffalon Casati; Francisco Humberto Nociti; Antônio Wilson Sallum; Enilson Antônio Sallum; Ikramuddin Aukhil; Shannon Margaret Wallet; Luciana Machion Shaddox
Journal:  Clin Oral Investig       Date:  2012-02-29       Impact factor: 3.573

3.  Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion.

Authors:  A Lourbakos; J Potempa; J Travis; M R D'Andrea; P Andrade-Gordon; R Santulli; E J Mackie; R N Pike
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 4.  Novel host response therapeutic approaches to treat periodontal diseases.

Authors:  Keith L Kirkwood; Joni A Cirelli; Jill E Rogers; William V Giannobile
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

5.  Relationship between C-telopeptide pyridinoline cross-links (ICTP) and putative periodontal pathogens in periodontitis.

Authors:  M D Palys; A D Haffajee; S S Socransky; W V Giannobile
Journal:  J Clin Periodontol       Date:  1998-11       Impact factor: 8.728

6.  Local inflammatory markers and systemic endotoxin in aggressive periodontitis.

Authors:  L M Shaddox; J Wiedey; N L Calderon; I Magnusson; E Bimstein; J A Bidwell; E F Zapert; I Aukhil; S M Wallet
Journal:  J Dent Res       Date:  2011-07-05       Impact factor: 6.116

Review 7.  B cells as under-appreciated mediators of non-auto-immune inflammatory disease.

Authors:  Barbara S Nikolajczyk
Journal:  Cytokine       Date:  2010-04-10       Impact factor: 3.861

8.  Low-level laser-aided orthodontic treatment of periodontally compromised patients: a randomised controlled trial.

Authors:  Chong Ren; Colman McGrath; Min Gu; Lijian Jin; Chengfei Zhang; Fung Hou Kumoi Mineaki Howard Sum; Ka Wai Frank Wong; Anson Cheuk Man Chau; Yanqi Yang
Journal:  Lasers Med Sci       Date:  2019-12-12       Impact factor: 3.161

9.  A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor κB Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis.

Authors:  Muna S Elburki; Carlos Rossa; Morgana R Guimarães-Stabili; Hsi-Ming Lee; Fabiana A Curylofo-Zotti; Francis Johnson; Lorne M Golub
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

Review 10.  The potential of p38 MAPK inhibitors to modulate periodontal infections.

Authors:  Keith L Kirkwood; Carlos Rossa
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.